Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Diseases

  Free Subscription


Articles published in Biochem Biophys Res Commun

Retrieve available abstracts of 127 articles:
HTML format



Single Articles


    December 2022
  1. NTAMBI JM
    The role of Stearoyl-CoA desaturase in hepatic de novo lipogenesis.
    Biochem Biophys Res Commun. 2022;633:81-83.
    PubMed     Abstract available


  2. ZHANG F, Wu J, Ruan H, Xia J, et al
    ZeXie decoction alleviates non-alcoholic fatty liver disease in rats: the study of genes, lipids, and gut microbiotas.
    Biochem Biophys Res Commun. 2022;632:129-138.
    PubMed     Abstract available


    November 2022
  3. ZHAO Q
    Mutant IDH1 attenuates hepatic lipogenesis through PTEN dependent pathway.
    Biochem Biophys Res Commun. 2022;637:254-258.
    PubMed     Abstract available


  4. KIM SQ, Mohallem R, Franco J, Buhman KK, et al
    Global landscape of protein complexes in postprandial-state livers from diet-induced obese and lean mice.
    Biochem Biophys Res Commun. 2022;629:40-46.
    PubMed     Abstract available


    October 2022
  5. WANG Q, Zheng K, Tan D, Liang G, et al
    TREM2 knockdown improves the therapeutic effect of PD-1 blockade in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2022;636.
    PubMed     Abstract available


  6. IQBAL T, Nawaz A, Karim M, Yaku K, et al
    Loss of hepatic Nmnat1 has no impact on diet-induced fatty liver disease.
    Biochem Biophys Res Commun. 2022;636.
    PubMed     Abstract available


  7. LEE KM, Hwang YJ, Jung GS
    Gemigliptin exerts protective effects against doxorubicin-induced hepatotoxicity by inhibiting apoptosis via the regulation of fibroblast growth factor 21 expression.
    Biochem Biophys Res Commun. 2022;626:135-141.
    PubMed     Abstract available


  8. TIAN-QI C, Yan-Fang D, Yan-Yan W, Yong-Hui Z, et al
    Butyrolactone I attenuates inflammation in murine NASH by inhibiting the NF-kappaB signaling pathway.
    Biochem Biophys Res Commun. 2022;626:167-174.
    PubMed     Abstract available


  9. LIN C, Yang H, Zhao W, Wang W, et al
    CTSB(+) macrophage repress memory immune hub in the liver metastasis site of colorectal cancer patient revealed by multi-omics analysis.
    Biochem Biophys Res Commun. 2022;626:8-14.
    PubMed     Abstract available


  10. OHKOSHI-YAMADA M, Kamimura K, Kimura A, Tanaka Y, et al
    Effects of a selective PPARalpha modulator, sodium-glucose cotransporter 2 inhibitor, and statin on the myocardial morphology of medaka nonalcoholic fatty liver disease model.
    Biochem Biophys Res Commun. 2022;625:116-121.
    PubMed     Abstract available


  11. TU H, Yin X, Wen J, Wu W, et al
    Glutaminase 1 blockade alleviates nonalcoholic steatohepatitis via promoting proline metabolism.
    Biochem Biophys Res Commun. 2022;634:1-9.
    PubMed     Abstract available


  12. HUANG Y, Liang W, Li K, Liao X, et al
    Sorafenib suppresses the activation of type I interferon pathway induced by RLR-MAVS and cGAS-STING signaling.
    Biochem Biophys Res Commun. 2022;623:181-188.
    PubMed     Abstract available


  13. CUI B, Yang L, Zhao Y, Lu X, et al
    HOXA13 promotes liver regeneration through regulation of BMP-7.
    Biochem Biophys Res Commun. 2022;623:23-31.
    PubMed     Abstract available


  14. SAMERI MJ, Savari F, Hoseinynejad K, Danyaei A, et al
    The hepato-protective effect of H2S-modified and non-modified mesenchymal stem cell exosomes on liver ischemia-reperfusion injury in mice: The role of MALAT1.
    Biochem Biophys Res Commun. 2022;635:194-202.
    PubMed     Abstract available


    September 2022
  15. ZHAO S, Liu X, Li L, Kong X, et al
    KIRA8 attenuates non-alcoholic steatohepatitis through inhibition of the IRE1alpha/XBP1 signalling pathway.
    Biochem Biophys Res Commun. 2022;632:158-164.
    PubMed     Abstract available


  16. ZHANG W, Xue H, Zhou C, Zheng Z, et al
    7-aminocephalosporanic acid, a novel HSP90beta inhibitor, attenuates HFD-induced hepatic steatosis.
    Biochem Biophys Res Commun. 2022;622:184-191.
    PubMed     Abstract available


  17. ZHONG F, Chen T, Li B
    Combinatorial transcriptional regulation of HEB/ZEB1/ASCL1 and MYBL2 on Ras/ErbB signaling.
    Biochem Biophys Res Commun. 2022;622:170-176.
    PubMed     Abstract available


  18. MAO X, Wu D, Xu N, Wang J, et al
    The danger signal interferon-induced protein 35 (IFP35) mediates acetaminophen-induced liver injury.
    Biochem Biophys Res Commun. 2022;621:25-31.
    PubMed     Abstract available


  19. SUN TT, Liu XL, Yang GY, Zhang W, et al
    Neurotrophic factors stimulate the activation of hepatic stellate cells in liver fibrosis.
    Biochem Biophys Res Commun. 2022;630:167-174.
    PubMed     Abstract available


  20. XU Y, Lu Y
    Alcoholic fatty liver is blunted by rFGF21 administration in mice lacking adipose FGFR1: The role of FGF21 in PPARalpha-mediated regulation of adipose tissue mass.
    Biochem Biophys Res Commun. 2022;619:84-89.
    PubMed     Abstract available


    August 2022
  21. CHU K, Zhao N, Hu X, Feng R, et al
    LncNONMMUG027912 alleviates lipid accumulation through AMPKalpha/mTOR/SREBP1C axis in nonalcoholic fatty liver.
    Biochem Biophys Res Commun. 2022;618:8-14.
    PubMed     Abstract available


  22. LEI X, Dai X, Wang Q, Long R, et al
    RNA-seq transcriptome profiling of liver regeneration in mice identifies the miR-34b-5p/phosphoinositide-dependent protein kinase 1 axis as a potential target for hepatocyte proliferation.
    Biochem Biophys Res Commun. 2022;627:111-121.
    PubMed     Abstract available


  23. LU Z, Yang H, Shao Y, Sun W, et al
    IGF2BP3-NRF2 axis regulates ferroptosis in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2022;627:103-110.
    PubMed     Abstract available


  24. JIA M, Xiao Y, Zhang C, Jiang T, et al
    Mitoxantrone alleviates hepatic steatosis induced by high-fat diet in broilers.
    Biochem Biophys Res Commun. 2022;627:52-59.
    PubMed     Abstract available


  25. PEI Y, Balogun O, Otieno D, Parks JS, et al
    The effects of brewers' spent grain on high-fat diet-induced fatty liver.
    Biochem Biophys Res Commun. 2022;616:49-55.
    PubMed     Abstract available


  26. CHEN Y, Zhang X
    TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells.
    Biochem Biophys Res Commun. 2022;625:23-30.
    PubMed     Abstract available


    July 2022
  27. LI L, Li S, Wang H, Li L, et al
    GSG2 promotes tumor growth through regulating cell proliferation in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2022;625:109-115.
    PubMed     Abstract available


  28. MORI J, Sawada T, Baba T, Hayakawa A, et al
    Identification of cell cycle-associated and -unassociated regulators for expression of a hepatocellular carcinoma oncogene cyclin-dependent kinase inhibitor 3.
    Biochem Biophys Res Commun. 2022;625:46-52.
    PubMed     Abstract available


  29. ZHOU J, Liu T, Xu H, Wang Y, et al
    LncRNA FIRRE promotes the proliferation and metastasis of hepatocellular carcinoma by regulating the expression of PXN through interacting with MBNL3.
    Biochem Biophys Res Commun. 2022;625:188-195.
    PubMed     Abstract available


  30. ZHANG X, Tao X, Feng F
    Downregulation of C12orf75 gene inhibits migration and invasion of liver cancer cell via suppressing the Wnt/beta-catenin signaling pathway in vitro.
    Biochem Biophys Res Commun. 2022;614:92-99.
    PubMed     Abstract available


  31. TANG C, Qiu S, Mou W, Xu J, et al
    Excessive activation of HOXB13/PIMREG axis promotes hepatocellular carcinoma progression and drug resistance.
    Biochem Biophys Res Commun. 2022;623:81-88.
    PubMed     Abstract available


  32. HU X, Pan H, Zhou S, Pang Q, et al
    HS1BP3, transcriptionally regulated by ESR1, promotes hepatocellular carcinoma progression.
    Biochem Biophys Res Commun. 2022;623:111-119.
    PubMed     Abstract available


  33. XU M, Wu X, Liu Z, Ding Y, et al
    A novel mouse model of diabetes, atherosclerosis and fatty liver disease using an AAV8-PCSK9-D377Y injection and dietary manipulation in db/db mice.
    Biochem Biophys Res Commun. 2022;622:163-169.
    PubMed     Abstract available


  34. GUO B, Xu X, Shao M, Yang X, et al
    UDP-glucose 6-dehydrogenase lessens sorafenib sensitivity via modulating unfolded protein response.
    Biochem Biophys Res Commun. 2022;613:207-213.
    PubMed     Abstract available


  35. XU Y, Denning KL, Lu Y
    PPARalpha agonist WY-14,643 induces the PLA2/COX-2/ACOX1 pathway to enhance peroxisomal lipid metabolism and ameliorate alcoholic fatty liver in mice.
    Biochem Biophys Res Commun. 2022;613:47-52.
    PubMed     Abstract available


  36. TOYOTA A, Goto M, Miyamoto M, Nagashima Y, et al
    Novel protein kinase cAMP-Activated Catalytic Subunit Alpha (PRKACA) inhibitor shows anti-tumor activity in a fibrolamellar hepatocellular carcinoma model.
    Biochem Biophys Res Commun. 2022;621:157-161.
    PubMed     Abstract available


    June 2022
  37. HONG W, Peng X, Zhou X, Li P, et al
    FXR/ASS1 axis attenuates the TAA-induced liver injury through arginine metabolism.
    Biochem Biophys Res Commun. 2022;611:31-37.
    PubMed     Abstract available


  38. MENG J, Zhang C, Wang D, Zhu L, et al
    Mitochondrial GCN5L1 regulates cytosolic redox state and hepatic gluconeogenesis via glycerol phosphate shuttle GPD2.
    Biochem Biophys Res Commun. 2022;621:1-7.
    PubMed     Abstract available


  39. GAO L, Zhang Y, Gao X, Xu L, et al
    Methylation of the HCBP6 promoter is associated with primary biliary cholangitis pathogenesis.
    Biochem Biophys Res Commun. 2022;610:176-181.
    PubMed     Abstract available


  40. KE X, Zhang R, Li P, Zuo L, et al
    Hydrochloride Berberine ameliorates alcohol-induced liver injury by regulating inflammation and lipid metabolism.
    Biochem Biophys Res Commun. 2022;610:49-55.
    PubMed     Abstract available


  41. JUNG SY, Yun HH, Lim JH, Lee DH, et al
    Hepatocyte-specific deletion of Bis causes senescence in the liver without deteriorating hepatic function.
    Biochem Biophys Res Commun. 2022;619:42-48.
    PubMed     Abstract available


  42. CAI Q, Zhu J, Cui X, Xia Y, et al
    S100A9 promotes inflammatory response in diabetic nonalcoholic fatty liver disease.
    Biochem Biophys Res Commun. 2022;618:127-132.
    PubMed     Abstract available


  43. LI S, Wang Y, Dun W, Han W, et al
    Phosphoproteomic analysis of FAC overload-triggered human hepatic cells reveals G2/M phase arrest.
    Biochem Biophys Res Commun. 2022;619:62-67.
    PubMed     Abstract available


  44. SAKURAI M, Weber P, Wolff G, Wieder A, et al
    TSC22D4 promotes TGFbeta1-induced activation of hepatic stellate cells.
    Biochem Biophys Res Commun. 2022;618:46-53.
    PubMed     Abstract available


  45. WU W, Lu P, Huang Y, Zhu Z, et al
    Emodin regulates the autophagy via the miR-371a-5p/PTEN axis to inhibit hepatic malignancy.
    Biochem Biophys Res Commun. 2022;619:1-8.
    PubMed     Abstract available


  46. FAN K, Zan X, Zhi Y, Yang Y, et al
    Immune response gene 1 deficiency impairs Nrf2 activation and aggravates liver fibrosis in mice.
    Biochem Biophys Res Commun. 2022;607:103-109.
    PubMed     Abstract available


  47. OH HA, Kim YJ, Moon KS, Seo JW, et al
    Identification of integrative hepatotoxicity induced by lysosomal phospholipase A2 inhibition of cationic amphiphilic drugs via metabolomics.
    Biochem Biophys Res Commun. 2022;607:1-8.
    PubMed     Abstract available


  48. HUANG L, He X, Peng W, He X, et al
    Hyperuricemia induces liver injury by upregulating HIF-1alpha and inhibiting arginine biosynthesis pathway in mouse liver and human L02 hepatocytes.
    Biochem Biophys Res Commun. 2022;617.
    PubMed     Abstract available


    May 2022
  49. MA Y, Li Q, Chen G, Tan Z, et al
    Transcriptomic analysis reveals a novel regulatory factor of ECHDC1 involved in lipid metabolism of non-alcoholic fatty liver disease.
    Biochem Biophys Res Commun. 2022;605:1-8.
    PubMed     Abstract available


  50. YOKOBORI K, Gruzdev A, Negishi M
    Mice blocking Ser347 phosphorylation of pregnane x receptor develop hepatic fasting-induced steatosis and hypertriglyceridemia.
    Biochem Biophys Res Commun. 2022;615:75-80.
    PubMed     Abstract available


  51. WEN H, He R, Wang H, Zhao S, et al
    Effects of small molecule inhibitor SW033291 on hepatic ischemia-reperfusion injury in mice.
    Biochem Biophys Res Commun. 2022;615:70-74.
    PubMed     Abstract available


  52. LI J, Huang L, Xiong W, Qian Y, et al
    Aerobic exercise improves non-alcoholic fatty liver disease by down-regulating the protein expression of the CNPY2-PERK pathway.
    Biochem Biophys Res Commun. 2022;603:35-40.
    PubMed     Abstract available


    April 2022
  53. LIU Q, Tang Q, Jing X, Zhang J, et al
    Mesencephalic astrocyte-derived neurotrophic factor protects against paracetamol -induced liver injury by inhibiting PERK-ATF4-CHOP signaling pathway.
    Biochem Biophys Res Commun. 2022;602:163-169.
    PubMed     Abstract available


  54. FUKUCHI T, Ueno T, Yamamoto T, Noguchi T, et al
    Liver progenitor cells may construct cysts having heterogeneous gene expression of liver-enriched transcription factors in mice with conditional knockout of the Hhex gene.
    Biochem Biophys Res Commun. 2022;602:49-56.
    PubMed     Abstract available


  55. ZHANG X, An T, Zhang X, Shen T, et al
    DDX17 protects hepatocytes against oleic acid/palmitic acid-induced lipid accumulation.
    Biochem Biophys Res Commun. 2022;612:169-175.
    PubMed     Abstract available


  56. LIAO C, Zhang L, Jiang R, Xu J, et al
    Inhibition of NAD kinase elevates the hepatic NAD(+) pool and alleviates acetaminophen-induced acute liver injury in mice.
    Biochem Biophys Res Commun. 2022;612:70-76.
    PubMed     Abstract available


  57. XIAO F, Xu F, Zhang H, Shuai X, et al
    Circ_0000591 served as endogenous RNA for miR-326 to promote progression of cholangiocarcinoma via the TLR4/MyD88/IL6 axis.
    Biochem Biophys Res Commun. 2022;600:101-108.
    PubMed     Abstract available


  58. WANG R, Ren Y, Bao T, Wang T, et al
    Inulin activates FXR-FGF15 signaling and further increases bile acids excretion in non-alcoholic fatty liver disease mice.
    Biochem Biophys Res Commun. 2022;600:156-162.
    PubMed     Abstract available


  59. EL-ASHMAWY NE, Khedr NF, Sallam M, Nossier AI, et al
    Effect of activation of liver X receptor alpha on cardiac & hepatic ABCC10 and SLC17A5 drug transporters in hypercholesterolemic rat model.
    Biochem Biophys Res Commun. 2022;610:133-139.
    PubMed     Abstract available


  60. XU ZX, Li JZ, Li Q, Xu MY, et al
    CircRNA608-microRNA222-PINK1 axis regulates the mitophagy of hepatic stellate cells in NASH related fibrosis.
    Biochem Biophys Res Commun. 2022;610:35-42.
    PubMed     Abstract available


  61. JUNG TW, Jeong JC, Park SY, Cho W, et al
    Abietic acid alleviates endoplasmic reticulum stress and lipid accumulation in human primary hepatocytes through the AMPK/ORP150 signaling.
    Biochem Biophys Res Commun. 2022;608:142-148.
    PubMed     Abstract available


  62. AI L, Wang Q, Cheng K
    Key genes in the liver fibrosis process are mined based on single-cell transcriptomics.
    Biochem Biophys Res Commun. 2022;598:131-137.
    PubMed     Abstract available


    March 2022
  63. FUNATO K, Otsuka M, Sekiba K, Miyakawa Y, et al
    Hepatitis B virus-associated hepatocellular carcinoma with Smc5/6 complex deficiency is susceptible to PARP inhibitors.
    Biochem Biophys Res Commun. 2022;607:89-95.
    PubMed     Abstract available


  64. YAN H, He N, He S
    HCG15 is a hypoxia-responsive lncRNA and facilitates hepatocellular carcinoma cell proliferation and invasion by enhancing ZNF641 transcription.
    Biochem Biophys Res Commun. 2022;608:170-176.
    PubMed     Abstract available


  65. NHO B, Ko KR, Kim S, Lee J, et al
    Intramuscular injection of a plasmid DNA vector expressing hepatocyte growth factor (HGF) ameliorated pain symptoms by controlling the expression of pro-inflammatory cytokines in the dorsal root ganglion.
    Biochem Biophys Res Commun. 2022;607:60-66.
    PubMed     Abstract available


  66. CHEN Z, Liu S, Xie P, Zhang B, et al
    Tumor-derived PD1 and PD-L1 could promote hepatocellular carcinoma growth through autophagy induction in vitro.
    Biochem Biophys Res Commun. 2022;605:82-89.
    PubMed     Abstract available


  67. SHU Z, Zhang G, Zhu X, Xiong W, et al
    Estrogen receptor alpha mediated M1/M2 macrophages polarization plays a critical role in NASH of female mice.
    Biochem Biophys Res Commun. 2022;596:63-70.
    PubMed     Abstract available


  68. CHEN R, Luo X, Jiang X, Deng S, et al
    Vinexin beta deficiency exacerbates diet-induced obesity, hepatosteatosis, insulin resistance and endoplasmic reticulum stress in mice.
    Biochem Biophys Res Commun. 2022;596:14-21.
    PubMed     Abstract available


  69. CHEN Q, Huang J, Tong W, Gui X, et al
    The geometry-dependent regulation of hepatic stellate cells by graphene oxide nanomaterials.
    Biochem Biophys Res Commun. 2022;604:179-184.
    PubMed     Abstract available


  70. ZHANG C, Lin J, Zhen C, Wang F, et al
    Amygdalin protects against acetaminophen-induced acute liver failure by reducing inflammatory response and inhibiting hepatocyte death.
    Biochem Biophys Res Commun. 2022;602:105-112.
    PubMed     Abstract available


    February 2022
  71. LI X, Yang M, Sun H, Ferdous MRU, et al
    Liver cyclophilin D deficiency inhibits the progression of early NASH by ameliorating steatosis and inflammation.
    Biochem Biophys Res Commun. 2022;594:168-176.
    PubMed     Abstract available


  72. SHI C, Pei M, Wang Y, Chen Q, et al
    Changes of flavin-containing monooxygenases and trimethylamine-N-oxide may be involved in the promotion of non-alcoholic fatty liver disease by intestinal microbiota metabolite trimethylamine.
    Biochem Biophys Res Commun. 2022;594:1-7.
    PubMed     Abstract available


  73. O G, Cascione S, Michielin F, Elvassore N, et al
    The emergence of the circadian clock network in hiPSC-derived hepatocytes on chip.
    Biochem Biophys Res Commun. 2022;601:109-115.
    PubMed     Abstract available


  74. YAMAGUCHI M, Ohbayashi S, Ooka A, Yamashita H, et al
    Harmine suppresses collagen production in hepatic stellate cells by inhibiting DYRK1B.
    Biochem Biophys Res Commun. 2022;600:136-141.
    PubMed     Abstract available


    January 2022
  75. QIAN M, Cao S, Wang T, Xu X, et al
    Apoptosis triggered by cytolethal distending toxin B subunit of Helicobacter hepaticus is aggravated by autophagy inhibition in mouse hepatocytes.
    Biochem Biophys Res Commun. 2022;598:40-46.
    PubMed     Abstract available


  76. KIMURA A, Kamimura K, Ohkoshi-Yamada M, Shinagawa-Kobayashi Y, et al
    Effects of a novel selective PPARalpha modulator, statin, sodium-glucose cotransporter 2 inhibitor, and combinatorial therapy on the liver and vasculature of medaka nonalcoholic steatohepatitis model.
    Biochem Biophys Res Commun. 2022;596:76-82.
    PubMed     Abstract available


  77. WANG M, Li B, Qin F, Ye J, et al
    Obesity induced Ext1 reduction mediates the occurrence of NAFLD.
    Biochem Biophys Res Commun. 2022;589:123-130.
    PubMed     Abstract available


  78. LEE N, Heo YJ, Choi SE, Jeon JY, et al
    Hepatoprotective effects of gemigliptin and empagliflozin in a murine model of diet-induced non-alcoholic fatty liver disease.
    Biochem Biophys Res Commun. 2022;588:154-160.
    PubMed     Abstract available


  79. KANDA Y, Ohata H, Miyazaki T, Sakai H, et al
    NF-kappaB suppression synergizes with E7386, an inhibitor of CBP/beta-catenin interaction, to block proliferation of patient-derived colon cancer spheroids.
    Biochem Biophys Res Commun. 2022;586:93-99.
    PubMed     Abstract available


    December 2021
  80. JUN H, ZeXin Z
    Screening of pyroptosis-related genes influencing the therapeutic effect of dehydroabietic acid in liver cancer and construction of a survival nomogram.
    Biochem Biophys Res Commun. 2021;585:103-110.
    PubMed     Abstract available


  81. CANG X, Wang Y, Zeng J, Gao J, et al
    C9orf72 knockdown alleviates hepatic insulin resistance by promoting lipophagy.
    Biochem Biophys Res Commun. 2021;588:15-22.
    PubMed     Abstract available


  82. LIU Z, Ma C, Wang Q, Yang H, et al
    Targeting FAM134B-mediated reticulophagy activates sorafenib-induced ferroptosis in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2021;589:247-253.
    PubMed     Abstract available


    November 2021
  83. SHI Y, Wei Q, Liu Y, Yuan J, et al
    The alleviating effect of sphingosine kinases 2 inhibitor K145 on nonalcoholic fatty liver.
    Biochem Biophys Res Commun. 2021;580:1-6.
    PubMed     Abstract available


  84. ZHANG WW, Xue R, Mi TY, Shen XM, et al
    Propofol ameliorates acute postoperative fatigue and promotes glucagon-regulated hepatic gluconeogenesis by activating CREB/PGC-1alpha and accelerating fatty acids beta-oxidation.
    Biochem Biophys Res Commun. 2021;586:121-128.
    PubMed     Abstract available


  85. SZTOLSZTENER K, Harasim-Symbor E, Chabowski A, Konstantynowicz-Nowicka K, et al
    The influence of dexamethasone on hepatic fatty acids metabolism and transport in human steatotic HepG2 cell line exposed to palmitate.
    Biochem Biophys Res Commun. 2021;585:132-138.
    PubMed     Abstract available


  86. LI Y, Dong J, Zhou Y, Ye X, et al
    Therapeutic effects of CXCL9-overexpressing human umbilical cord mesenchymal stem cells on liver fibrosis in rats.
    Biochem Biophys Res Commun. 2021;584:87-94.
    PubMed     Abstract available


    October 2021
  87. LIU H, Wang M, Jin Z, Sun D, et al
    FNDC5 induces M2 macrophage polarization and promotes hepatocellular carcinoma cell growth by affecting the PPARgamma/NF-kappaB/NLRP3 pathway.
    Biochem Biophys Res Commun. 2021;582:77-85.
    PubMed     Abstract available


  88. FANG J, Liang W
    ASCs -derived exosomes loaded with vitamin A and quercetin inhibit rapid senescence-like response after acute liver injury.
    Biochem Biophys Res Commun. 2021;572:125-130.
    PubMed     Abstract available


    September 2021
  89. CHO J, Tsugawa Y, Imai Y, Imai T, et al
    Chorionic gonadotropin stimulates maternal hepatocyte proliferation during pregnancy.
    Biochem Biophys Res Commun. 2021;579:110-115.
    PubMed     Abstract available


  90. XU L, Yang C, Wang J, Li Z, et al
    Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
    Biochem Biophys Res Commun. 2021;578:142-149.
    PubMed     Abstract available


  91. JIN Y, Yang R, Ding J, Zhu F, et al
    KAT6A is associated with sorafenib resistance and contributes to progression of hepatocellular carcinoma by targeting YAP.
    Biochem Biophys Res Commun. 2021;585:185-190.
    PubMed     Abstract available


    August 2021
  92. HUANG T, Yu J, Luo Z, Yu L, et al
    Translatome analysis reveals the regulatory role of betaine in high fat diet (HFD)-induced hepatic steatosis.
    Biochem Biophys Res Commun. 2021;575:20-27.
    PubMed     Abstract available


  93. WANG Z, Qu K, Zhou L, Ren L, et al
    Apaf1 nanoLuc biosensors identified lentinan as a potent synergizer of cisplatin in targeting hepatocellular carcinoma cells.
    Biochem Biophys Res Commun. 2021;577:45-51.
    PubMed     Abstract available


  94. CHEN B, Cha JH, Yan M, Cao N, et al
    ATXN7L3B promotes hepatocellular carcinoma stemness and is downregulated by metformin.
    Biochem Biophys Res Commun. 2021;573:1-8.
    PubMed     Abstract available


    July 2021
  95. KIM H, Lee JY, Park SJ, Kwag E, et al
    ZNF746/PARIS promotes the occurrence of hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2021;563:98-104.
    PubMed     Abstract available


  96. LIU P, Xia P, Fu Q, Liu C, et al
    miR-199a-5p inhibits the proliferation of hepatocellular carcinoma cells by regulating CDC25A to induce cell cycle arrest.
    Biochem Biophys Res Commun. 2021;571:96-103.
    PubMed     Abstract available


  97. LEILEI L, Xue S, Yan L, Yuyuan L, et al
    PM2.5-exposed hepatocytes induce hepatic stellate cells activation by releasing TGF-beta1.
    Biochem Biophys Res Commun. 2021;569:125-131.
    PubMed     Abstract available


    June 2021
  98. HE Y, Pei JH, Li XQ, Chi G, et al
    IL-35 promotes EMT through STAT3 activation and induces MET by promoting M2 macrophage polarization in HCC.
    Biochem Biophys Res Commun. 2021;559:35-41.
    PubMed     Abstract available


  99. YU HM, Chung HK, Park KS
    The PDE5 inhibitor udenafil ameliorates nonalcoholic fatty liver disease by improving mitochondrial function.
    Biochem Biophys Res Commun. 2021;558:57-63.
    PubMed     Abstract available


  100. LIU C, Huang XY, Huang Y
    FAM83G promotes proliferation, invasion, and metastasis by regulating PI3K/AKT signaling in hepatocellular carcinoma cells.
    Biochem Biophys Res Commun. 2021;567:63-71.
    PubMed     Abstract available


  101. OUYANG X, Yao L, Liu G, Liu S, et al
    Loss of androgen receptor promotes HCC invasion and metastasis via activating circ-LNPEP/miR-532-3p/RAB9A signal under hypoxia.
    Biochem Biophys Res Commun. 2021;557:26-32.
    PubMed     Abstract available


  102. LI Y, Yi Q, Liao X, Han C, et al
    Hypomethylation-driven overexpression of HJURP promotes progression of hepatocellular carcinoma and is associated with poor prognosis.
    Biochem Biophys Res Commun. 2021;566:67-74.
    PubMed     Abstract available


  103. MA Y, Sun W, Zhang Q, Gao B, et al
    lncRNA BSG-AS1 is hypoxia-responsive and promotes hepatocellular carcinoma by enhancing BSG mRNA stability.
    Biochem Biophys Res Commun. 2021;566:101-107.
    PubMed     Abstract available


  104. ZENG Z, Shi Z, Liu Y, Zhao J, et al
    HIF-1alpha-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression.
    Biochem Biophys Res Commun. 2021;566:80-86.
    PubMed     Abstract available


  105. SATO T, Tsuchiya A, Owaki T, Kumagai M, et al
    Severe steatosis and mild colitis are important for the early occurrence of hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2021;566:36-44.
    PubMed     Abstract available


    May 2021
  106. WANG Y, Yang H, Zhang G, Luo C, et al
    hsa-miR-7-5p suppresses proliferation, migration and promotes apoptosis in hepatocellular carcinoma cell lines by inhibiting SPC24 expression.
    Biochem Biophys Res Commun. 2021;561:80-87.
    PubMed     Abstract available


  107. YUAN Y, Yuan HF, Geng Y, Zhao LN, et al
    Aspirin modulates 2-hydroxyisobutyrylation of ENO1K281 to attenuate the glycolysis and proliferation of hepatoma cells.
    Biochem Biophys Res Commun. 2021;560:172-178.
    PubMed     Abstract available


  108. PHO-IAM T, Punnakitikashem P, Somboonyosdech C, Sripinitchai S, et al
    PLGA nanoparticles containing alpha-fetoprotein siRNA induce apoptosis and enhance the cytotoxic effects of doxorubicin in human liver cancer cell line.
    Biochem Biophys Res Commun. 2021;553:191-197.
    PubMed     Abstract available


  109. GOTO N, Shibutani S, Miura N, Watanabe R, et al
    Thapsigargin suppresses alpha 1-acid glycoprotein secretion independently of N-glycosylation and ER stress.
    Biochem Biophys Res Commun. 2021;552:30-36.
    PubMed     Abstract available


  110. ZHANG Q, Yang M, Qu Z, Zhou J, et al
    Corrigendum to Autophagy prevention sensitizes AKTi-1/2-induced anti-hepatocellular carcinoma cell activity in vitro and in vivo" [Biochem. Biophys. Res. Commun. (2016) 480(3) 334-340].
    Biochem Biophys Res Commun. 2021 May 5. pii: S0006-291X(21)00735.
    PubMed    


  111. YANG X, Yao B, Niu Y, Chen T, et al
    Corrigendum to hypoxia-induced lncRNA EIF3J-AS1 accelerates hepatocellular carcinoma progression via targeting miR-122-5p/CTNND2 axis.
    Biochem Biophys Res Commun. 2021 May 5. pii: S0006-291X(21)00729.
    PubMed    


    April 2021
  112. OHYA K, Imamura M, Teraoka Y, Uchida T, et al
    Novel drug resistance-associated substitutions against pibrentasvir emerged in genotype 1b hepatitis C virus-infected human hepatocyte transplanted mice.
    Biochem Biophys Res Commun. 2021;559:78-83.
    PubMed     Abstract available


  113. YAN L, Zhang X, Fu J, Liu Q, et al
    Inhibition of the transient receptor potential vanilloid 3 channel attenuates carbon tetrachloride-induced hepatic fibrosis.
    Biochem Biophys Res Commun. 2021;558:86-93.
    PubMed     Abstract available


  114. ZHANG H, Yao W, Zhang M, Lu Y, et al
    TTK inhibitor promotes radiosensitivity of liver cancer cells through p21.
    Biochem Biophys Res Commun. 2021;550:84-91.
    PubMed     Abstract available


  115. WANG TT, Hong YF, Chen ZH, Wu DH, et al
    Synergistic effects of alpha-Mangostin and sorafenib in hepatocellular carcinoma: New insights into alpha-mangostin cytotoxicity.
    Biochem Biophys Res Commun. 2021;558:14-21.
    PubMed     Abstract available


  116. KATO T, Murata D, Anders RA, Sesaki H, et al
    Nuclear PTEN and p53 suppress stress-induced liver cancer through distinct mechanisms.
    Biochem Biophys Res Commun. 2021;549:83-90.
    PubMed     Abstract available


  117. YOSHINO K, Hosooka T, Shinohara M, Aoki C, et al
    Canagliflozin ameliorates hepatic fat deposition in obese diabetic mice: Role of prostaglandin E2.
    Biochem Biophys Res Commun. 2021;557:62-68.
    PubMed     Abstract available


  118. LI G, Du P, He J, Li Y, et al
    CircRNA circBACH1 (hsa_circ_0061395) serves as a miR-656-3p sponge to facilitate hepatocellular carcinoma progression through increasing SERBP1 expression.
    Biochem Biophys Res Commun. 2021;556:1-8.
    PubMed     Abstract available


  119. WU M, Chen P, Liu F, Lv B, et al
    ONX0912, a selective oral proteasome inhibitor, triggering mitochondrial apoptosis and mitophagy in liver cancer.
    Biochem Biophys Res Commun. 2021;547:102-110.
    PubMed     Abstract available


  120. LI D, Xie P, Zhao S, Zhao J, et al
    Hepatocytes derived increased SAA1 promotes intrahepatic platelet aggregation and aggravates liver inflammation in NAFLD.
    Biochem Biophys Res Commun. 2021;555:54-60.
    PubMed     Abstract available


    March 2021
  121. FAN Z, Gao Y, Zhang W, Yang G, et al
    METTL3/IGF2BP1/CD47 contributes to the sublethal heat treatment induced mesenchymal transition in HCC.
    Biochem Biophys Res Commun. 2021;546:169-177.
    PubMed     Abstract available


  122. PARK NY, Jo DS, Park SJ, Lee H, et al
    Depletion of HNRNPA1 induces peroxisomal autophagy by regulating PEX1 expression.
    Biochem Biophys Res Commun. 2021;545:69-74.
    PubMed     Abstract available


  123. XIN Y, Xu L, Zhang X, Yang C, et al
    Sirtuin 6 ameliorates alcohol-induced liver injury by reducing endoplasmic reticulum stress in mice.
    Biochem Biophys Res Commun. 2021;544:44-51.
    PubMed     Abstract available


    February 2021
  124. ZHANG Y, Sun Y, Zhang Y, Miao Q, et al
    Nuclear factor Y participates in alcoholic liver disease by activating SREBP1 expression in mice.
    Biochem Biophys Res Commun. 2021;541:90-94.
    PubMed     Abstract available


  125. YANG M, Cui Y, Song J, Cui C, et al
    Mesenchymal stem cell-conditioned medium improved mitochondrial function and alleviated inflammation and apoptosis in non-alcoholic fatty liver disease by regulating SIRT1.
    Biochem Biophys Res Commun. 2021;546:74-82.
    PubMed     Abstract available


    January 2021
  126. XIAO T, Cui Y, Ji H, Yan L, et al
    Baicalein attenuates acute liver injury by blocking NLRP3 inflammasome.
    Biochem Biophys Res Commun. 2021;534:212-218.
    PubMed     Abstract available


  127. LI Y, Xia J, Shao F, Zhou Y, et al
    Sorafenib induces mitochondrial dysfunction and exhibits synergistic effect with cysteine depletion by promoting HCC cells ferroptosis.
    Biochem Biophys Res Commun. 2021;534:877-884.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: